Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1539-0829
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease ; volume:21 ; number:7 ; day:11 ; month:5 ; year:2021 ; pages:1-6 ; date:7.2021
Current diabetes reports ; 21, Heft 7 (11.5.2021), 1-6, 7.2021
- Creator
-
Hasegawa, Sho
Inagi, Reiko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11892-021-01390-8
- URN
-
urn:nbn:de:101:1-2021092121145958427036
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hasegawa, Sho
- Inagi, Reiko
- SpringerLink (Online service)
Other Objects (12)
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Towards soundscape fingerprinting: development, analysis and assessment of underlying acoustic dimensions to describe acoustic environments
Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemia
Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances
When Should We Describe Species?
Metabolomics
Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort
Evaluating functions to describe point patterns
Using ontologies to describe mouse phenotypes
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Towards soundscape fingerprinting: development, analysis and assessment of underlying acoustic dimensions to describe acoustic environments
Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemia
Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances
When Should We Describe Species?
Metabolomics
Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort
Evaluating functions to describe point patterns
Using ontologies to describe mouse phenotypes
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Towards soundscape fingerprinting: development, analysis and assessment of underlying acoustic dimensions to describe acoustic environments
Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemia
Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances
When Should We Describe Species?
Metabolomics
Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort
Evaluating functions to describe point patterns